Delivery Order SPE2DE24D0013-SPE2D625F3RLE
- Not listed
- The U.S. Defense Department's Medical Supply Chain awarded a $204,000 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on September 15, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by September 22, 2025, and carries no set-aside designation. This award represents a continuation of the department's partnership with Cepheid to procure diagnostic testing solutions, specifically for...
- The U.S. Department of Defense's Medical Supply Chain awarded a $3,400 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on September 10, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by September 17, 2025, and carries no set-aside designation. The contract nomenclature indicates the order involves diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial...
- The Defense Department's Medical Supply Chain awarded a $25,920 firm fixed-price delivery order to Cepheid Inc. on September 9, 2025, with an ultimate completion date of September 16, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic solutions from the Sunnyvale, California-based manufacturer, likely supporting testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV) detection across federal healthcare systems. This award carries...
- The U.S. Defense Department's Medical Supply Chain awarded a $8,640 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on September 9, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, is for diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection, with performance completion targeted for September 16, 2025. The contract contains no set-aside designation and represents a...
- The U.S. Defense Department's Medical Supply Chain awarded a $2,960 firm fixed-price delivery order to Cepheid Inc. on September 17, 2025, with an ultimate completion date of September 24, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). Cepheid, a Sunnyvale, California-based manufacturer specializing in molecular diagnostic systems and test kits for infectious diseases,...
- The U.S. Defense Department's Medical Supply Chain awarded a $8,160 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California, on September 2, 2025. This delivery order, designated 4569302270 for XPCOV2/FLU/RSV-10 testing solutions, is scheduled for completion by September 9, 2025, with work performed at the contractor's Sunnyvale facility. The award carries no small business set-aside designation and represents part of...
- The U.S. Defense Department's Medical Supply Chain awarded a $6,800 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, for XPCOV2/FLU/RSV-10 testing solutions. This delivery order, issued on July 18, 2025, with an ultimate completion date of July 25, 2025, carries no set-aside designation and represents procurement of diagnostic testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The...
- The U.S. Defense Department's Medical Supply Chain awarded a $3,400 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems, on September 10, 2025. The delivery order, designated XPCOV2/FLU/RSV-10 with an ultimate completion date of September 17, 2025, carries no set-aside designation. This award represents a procurement of diagnostic testing solutions, specifically reagents and test kits for detecting COVID-19, influenza, and...
- The U.S. Department of Defense, through its Medical Supply Chain division, awarded a $20,400 firm fixed-price delivery order to Cepheid Inc. on July 10, 2025, with an ultimate completion date of July 17, 2025. The contract, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). Cepheid, a Sunnyvale, California-based manufacturer specializing in advanced diagnostic systems, will perform the work at its...
- The U.S. Defense Department's Medical Supply Chain awarded a $17,680 firm fixed-price delivery order to Cepheid Inc. on September 8, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The delivery order, designated XPCOV2/FLU/RSV-10, is set to be completed by September 15, 2025, with performance conducted at Cepheid's headquarters in Sunnyvale, California. This award carries no set-aside designation and represents a...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F3RLEDelivery Order
The U.S. Defense Department's Medical Supply Chain awarded a $3,740 firm fixed-price delivery order to Cepheid Inc. on September 17, 2025, for XPCOV2/FLU/RSV-10 molecular diagnostic solutions. The contract, with a completion date of October 1, 2025, represents a delivery order under one of Cepheid's existing Indefinite Delivery Vehicle contracts with the Department of Veterans Affairs. The award carries no set-aside designation and is for performance at Cepheid's headquarters in Sunnyvale, California. Cepheid, a leading provider of molecular diagnostic systems and test kits, specializes in detecting infectious diseases including COVID-19, influenza, and respiratory syncytial virus (RSV)—the conditions specified in this delivery order's designation. The company maintains significant federal relationships through multiple IDV contracts valued in the tens of millions of dollars with VA Veterans Integrated Service Networks and the Defense Logistics Agency, positioning it as a key supplier of diagnostic reagents, assays, and testing services to federal healthcare systems. This delivery order reflects the ongoing federal demand for rapid molecular diagnostic capabilities across defense and veterans' healthcare infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 9/17/25 |